Thyroid

Around 200 million people worldwide have some form of thyroid disease. Worldwide, it is estimated that 1 billion people are at risk of developing a thyroid goiter. Statistically, women are 5 to 8 times more likely than men to develop some form of thyroid disease.

Along with the traditional and consolidated first line assays for assessing the thyroid function (FT4, TSH) DiaSorin offers the opportunity to further investigate thyroid diseases with FT3 assays and an assay for the measurement of autoantibodies to Thyroid Peroxidase (TPO).

DiaSorin offers tests for many of the major Thyroid markers for diagnosis, follow-up and monitoring of treatment of thyroid diseases using either RIA technology or the LIAISON® systems.

INTERNATIONAL	USA
Disclaimer: the DIASORIN site content linked here is for outside the United States only. Continue to our International Section	Disclaimer: the DIASORIN site content linked here is for United States only. Continue to our US Section
Ai sensi delle Linee Guida del Ministero della Salute del 28/03/2013, relative alla pubblicità sanitaria concernente i dispositivi medici, dispositivi medico-diagnostici in vitro e presidi medico-chirurgici, si avvisa l'utente che le informazioni contenute nel presente sito Internet e alle quali si sta per accedere sono esclusivamente rivolte agli operatori professionali Pursuant to the Guidelines of the Ministry of Health dated 28/03/2013 related to health advertising concerning medical devices, in vitro diagnostic medical devices and medical-surgical devices, we hereby inform you that the information contained in this website and to which you are going to access is exclusively intended for professional operators

INTERNATIONAL

USA

Disclaimer: the DIASORIN site content linked here is for outside the United States only.

Continue to our

International Section

Disclaimer: the DIASORIN site content linked here is for United States only.

Continue to our

US Section

Ai sensi delle Linee Guida del Ministero della Salute del 28/03/2013, relative alla pubblicità sanitaria concernente i dispositivi medici, dispositivi medico-diagnostici in vitro e presidi medico-chirurgici, si avvisa l'utente che le informazioni contenute nel presente sito Internet e alle quali si sta per accedere sono esclusivamente rivolte agli operatori professionali

Pursuant to the Guidelines of the Ministry of Health dated 28/03/2013 related to health advertising concerning medical devices, in vitro diagnostic medical devices and medical-surgical devices, we hereby inform you that the information contained in this website and to which you are going to access is exclusively intended for professional operators

Contacts